(Q38316102)

2 September 2017

title

Downregulated expression of hepatoma-derived growth factor (HDGF) reduces gallbladder cancer cell proliferation and invasion (English)

1 reference

2 September 2017

1 reference

Maolan Li

1

1 reference

2 September 2017

Jun Shen

2

1 reference

2 September 2017

Xiangsong Wu

3

1 reference

2 September 2017

Bingtai Zhang

4

1 reference

2 September 2017

Rui Zhang

5

1 reference

2 September 2017

Hao Weng

6

1 reference

2 September 2017

Qian Ding

7

1 reference

2 September 2017

Zhujun Tan

8

1 reference

2 September 2017

Guofeng Gao

9

1 reference

2 September 2017

Jiasheng Mu

10

1 reference

2 September 2017

Jiahua Yang

11

1 reference

2 September 2017

Yijun Shu

12

1 reference

2 September 2017

Runfa Bao

13

1 reference

2 September 2017

Qichen Ding

14

1 reference

2 September 2017

Wenguang Wu

15

1 reference

2 September 2017

Yang Cao

16

1 reference

2 September 2017

Yingbin Liu

17

1 reference

2 September 2017

publication date

23 April 2013

1 reference

2 September 2017

1 reference

2 September 2017

volume

30

1 reference

2 September 2017

issue

2

1 reference

2 September 2017

page(s)

587

1 reference

https://scigraph.springernature.com/pub.10.1007/s12032-013-0587-7

2 September 2017

exact match

0 references

cites work

Gallbladder cancer: lessons from a rare tumour

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0587-7

Gallbladder cancer: past, present and an uncertain future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0587-7

Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0587-7

Diverse cellular transformation capability of overexpressed genes in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0587-7

Hepatoma-derived growth factor and nucleolin exist in the same ribonucleoprotein complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0587-7

The expression and prognostic significance of hepatoma-derived growth factor in oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0587-7

Hepatoma-derived growth factor involved in the carcinogenesis of gastric epithelial cells through promotion of cell proliferation by Erk1/2 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0587-7

Apoptosis of human colorectal carcinoma cells is induced by blocking hepatoma-derived growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0587-7

shRNA targeting HDGF suppressed cell growth and invasion of squamous cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0587-7

Hepatoma-derived growth factor is a novel prognostic factor for patients with pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0587-7

Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0587-7

Ethyl pyruvate administration suppresses growth and invasion of gallbladder cancer cells via downregulation of HMGB1-RAGE axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0587-7

Antibodies targeting hepatoma-derived growth factor as a novel strategy in treating lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0587-7

Hepatoma-derived growth factor stimulates podosome rosettes formation in NIH/3T3 cells through the activation of phosphatidylinositol 3-kinase/Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0587-7

Tumorigenesis and prognostic role of hepatoma-derived growth factor in human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0587-7

p53 negatively regulates the hepatoma growth factor HDGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0587-7

Hepatoma-derived growth factor regulates breast cancer cell invasion by modulating epithelial--mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0587-7

Overexpressed HDGF as an independent prognostic factor is involved in poor prognosis in Chinese patients with liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0587-7

Prognostic value of nuclear hepatoma-derived growth factor (HDGF) localization in patients with breast cancer

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23609195

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Expression level of hepatoma-derived growth factor correlates with tumor recurrence of esophageal carcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23609195

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S12032-013-0587-7

1 reference

Dimensions Publication ID

2 September 2017

1052064139

0 references

1 reference